News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Venetoclax and Pegcrisantaspase for Relapsed or Refractory Acute Myeloid Leukemia
Yuchen Liu/sightmd.com
Nov 2, 2024, 17:34

Venetoclax and Pegcrisantaspase for Relapsed or Refractory Acute Myeloid Leukemia

Anand Patel, Assistant Professor and Director of the Inpatient Leukemia Service at the University of Chicago, shared a recent article by Yuchen Liu on X:

“Very interesting study in Blood Journal looking at Pegcrisantaspase + Ven in R/R AML (68% of patients with prior Ven exposure)!”

Venetoclax and Pegcrisantaspase for Relapsed or Refractory Acute Myeloid Leukemia

A phase 1 study of the amino acid modulator pegcrisantaspase and venetoclax in relapsed or refractory acute myeloid leukemia.

Authors: Yuchen Liu, et al.

Venetoclax and Pegcrisantaspase for Relapsed or Refractory Acute Myeloid Leukemia

 

Acute Myeloid Leukemia AML Anand Patel Blood Journal cancer OncoDaily Oncology Pegcrisantaspase venetoclax Yuchen Liu
Special Coverage
Blog
Mar 31, 2025, 20:43
Akhil Santhosh: Pembrolizumab and lenvatinib show promise in mesothelioma treatment
Blog
Mar 31, 2025, 20:25
Happy National Doctors’ Day - Mount Sinai Department of Medicine
Blog
Mar 31, 2025, 20:25
A rare glimpse inside doctors’ offices - Moffitt Cancer Center
Blog
Mar 31, 2025, 20:00
2 open positions in the IASLC team
Blog
Mar 31, 2025, 19:08
Predicting response to neoadjuvant chemotherapy in MIBC via interpretable multimodal deep learning
Blog
Mar 31, 2025, 19:01
Colorectal cancer affects all ages: learn your risks - Digestive Cancers Europe
Blog
Mar 31, 2025, 18:51
Insights from GUtrends25 on Urothelial Cancer Treatment by Tom Powles
Blog
Mar 31, 2025, 18:40
Celebrating National Doctors Day - Dolphins Cancer Challenge
Blog
Mar 31, 2025, 18:40
Serre-Beinier Veronique: Key Insights from ELCC 2025
Blog
Mar 31, 2025, 18:35
Binay Shah: Excited to break down barriers and bring quality care to those who need it most
Blog
Mar 31, 2025, 18:27
Bernard A. Fox: UbiVac Seeks Support and Partners to Bring DPV-001 Immunotherapy to Pediatric Cancer Trials
Career
Mar 31, 2025, 18:22
Maryam Yazdy has been appointed as the Senior Medical Director of Clinical Development at BeiGene